The Childrens Cancer Study Group conducted four therapeutic studies on a total of 1006 children with acute nonlymphocytic leukemia from 1972 to 1983. This report describes the therapeutic strategies of these studies and examines trends in induction rates and long-term outcome over this period. The r
Congenital abnormalities in children with acute leukemia: A report from the Children’s Cancer Group
✍ Scribed by Ann C. Mertens; Wanqing Wen; Stella M. Davies; Michael Steinbuch; Jonathan D. Buckley; John D. Potter; Leslie L. Robison
- Book ID
- 117166033
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 128 KB
- Volume
- 133
- Category
- Article
- ISSN
- 1097-6833
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The authors are thankful to a parent whose financial support provided much assistance in achieving the very high rate of follow-up neurodevelopmental evaluations. They also acknowledge the following individuals for their special efforts in locating children and helping to arrange a significant numbe
Amsacrine (AMSA) and cyclocytidine were studied as retrieval therapy in 122 pediatric patients with acute nonlymphoblastic leukemia (ANLL). Patients either failed to achieve sustained initial remissions or were in relapse. Induction therapy consisted of intravenous (IV) AMSA (75 mg/mz) from days 1 t
## Background: The authors have determined the prognostic significance of cytogenetically detectable 12p abnormalities, which are frequent in children with acute lymphoblastic leukemia (all), in a large cohort of patients treated on risk-adjusted protocols of the children's cancer group (ccg). ##